Clinical Trial of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Population Aged 3 to 17 Years(COVID-19)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This study is a randomized, double-blinded, and placebo controlled phase Ⅰ clinical trial of the SARS-CoV-2 inactivated vaccine to evaluate the safety and immunogenicity of the experimental vaccine in healthy population aged 3 to 17 years.
Epistemonikos ID: 3b0d57c78366514f38a01493bcf118a301e85d6f
First added on: Aug 13, 2021